Study Finds That Mental Health is Essential in Recovery from Cardiac Events

Recent research that was presented at the 70th Annual Scientific Session, which is held by the American College of Cardiology, has found that middle-aged and young adults who have been diagnosed with conditions such as anxiety or depression after they’ve suffered cardiac arrest have twice a higher chance of suffering from a second heart attack when compared with individuals who experience mild levels of distress.

Researchers noted that the study evaluates how mental health impacts the outlook for cardiac arrest survivors. They added that they also tracked inflammatory markers that may contribute to an increased risk of cardiovascular diseases among individuals who experience distress. The study’s findings align with results from prior studies conducted on older individuals, which supports evidence that mental health is an essential part of an individual’s recovery after a cardiac event.

The lead author of the study, who’s also an Emory University cardiology fellow, Mariana Garcia, stated that the team’s findings suggest that cardiologists should consider offering psychological assessments, especially in young patients. Additionally, she continued, healthcare providers should also consider treatment methods that improve psychological distress in young patients after a cardiac event, such as holistic approaches and meditation.

The researchers examined health outcomes in more than 280 cardiac arrest survivors between the ages of 18 and 61, with the average age being 51. Participants of the study had to complete questionnaires that measured post-traumatic stress disorder and perceived stress, anger, anxiety and depression half a year after their heart attack.

They found that of the participants, 80 suffered a stroke or another cardiac arrest within five years of their first attack. This number, they noted, either died from cardiovascular causes or were hospitalized for heart failure. The researchers added that, when compared with individuals who experienced mild levels of distress, these outcomes were observed in 47% of the patients who experienced high levels of distress.

They also found that individuals who experienced high levels of distress also had in their blood higher levels of monocyte chemoattract protein-1 and interleukin-6, both of which which are inflammatory markers, after mental stress and during rest. These markers have been linked to unfavorable cardiac events and plaque buildup in arteries and are known to increase when an individual is under mental stress.

In addition to this, the researchers also discovered that individuals with high levels of distress were more often female and Black and more often came from a socioeconomic background that was disadvantaged. Furthermore, they were more likely to have high blood pressure or diabetes, and they smoked.

Given that mental health issues and cardiac events can affect brain health, it isn’t surprising that several companies, including Brain Scientific Inc. (OTCQB: BRSF), have specialized in developing software as well as advanced devices to facilitate neurology diagnostics so that any problem affecting the brain can be detected quickly and definitively.

NOTE TO INVESTORS: The latest news and updates relating to Brain Scientific Inc. (OTCQB: BRSF) are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.